18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease
Clinical trial NCT02031198 · COMPLETED
Trial details
- NCT number
- NCT02031198
- Sponsor
- Axon Neuroscience SE
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2016-08-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.